Your browser doesn't support javascript.
loading
SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.
Dardaei, Leila; Wang, Hui Qin; Singh, Manrose; Fordjour, Paul; Shaw, Katherine X; Yoda, Satoshi; Kerr, Grainne; Yu, Kristine; Liang, Jinsheng; Cao, Yichen; Chen, Yan; Lawrence, Michael S; Langenbucher, Adam; Gainor, Justin F; Friboulet, Luc; Dagogo-Jack, Ibiayi; Myers, David T; Labrot, Emma; Ruddy, David; Parks, Melissa; Lee, Dana; DiCecca, Richard H; Moody, Susan; Hao, Huaixiang; Mohseni, Morvarid; LaMarche, Matthew; Williams, Juliet; Hoffmaster, Keith; Caponigro, Giordano; Shaw, Alice T; Hata, Aaron N; Benes, Cyril H; Li, Fang; Engelman, Jeffrey A.
Afiliación
  • Dardaei L; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Wang HQ; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Singh M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Fordjour P; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Shaw KX; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Yoda S; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Kerr G; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Yu K; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Liang J; Novartis Institutes for BioMedical Research, Basal, Switzerland.
  • Cao Y; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Chen Y; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Lawrence MS; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Langenbucher A; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Gainor JF; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Friboulet L; Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
  • Dagogo-Jack I; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Myers DT; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Labrot E; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Ruddy D; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Parks M; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Lee D; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • DiCecca RH; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Moody S; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Hao H; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Mohseni M; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • LaMarche M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Williams J; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Hoffmaster K; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Caponigro G; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Shaw AT; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Hata AN; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Benes CH; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Li F; Cancer Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Engelman JA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Nat Med ; 24(4): 512-517, 2018 05.
Article en En | MEDLINE | ID: mdl-29505033
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Reordenamiento Génico / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Proteína Tirosina Fosfatasa no Receptora Tipo 11 / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Reordenamiento Génico / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Proteína Tirosina Fosfatasa no Receptora Tipo 11 / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos